A. D. Beadell Investment Counsel, Inc. Charles River Laboratories International, Inc. Transaction History

A. D. Beadell Investment Counsel, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$249.67 - $299.48 $1.48 Million - $1.78 Million	-5,935 Closed	0 $0
Q4 2020 Jan 15, 2021	SELL	$222.0 - $252.62 $275,280 - $313,248	-1,240 Reduced 17.28%	5,935 $1.48 Million
Q3 2020 Nov 02, 2020	SELL	$175.56 - $226.45 $625,871 - $807,294	-3,565 Reduced 33.19%	7,175 $1.62 Million
Q1 2020 Apr 22, 2020	BUY	$98.9 - $178.34 $1.06 Million - $1.92 Million	10,740 New	10,740 $1.36 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of A. D. Beadell Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on A. D. Beadell Investment Counsel, Inc. with notifications on news.